Ampicillin in the Treatment of Chronic Typhoid Carriers
- 13 April 1966
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 274 (15), 807-815
- https://doi.org/10.1056/nejm196604142741501
Abstract
THE only known reservoir of Salmonella typhosa is the human patient or carrier.1 Some 500 to 2000 cases of typhoid fever have occurred annually in the United States over the past ten years,2 , 3 approximately 3 per cent in patients destined to become chronic carriers.1 A significant fraction of acute cases is traced to domestic infection derived from chronic fecal carriers. The sources of infection for the bulk of the remainder are never identified but are almost certainly contamination of comestibles by ambulatory patients or carriers.In 1962 Tynes and Utz4 reported that approximately 3600 chronic carriers of S. typhosa were . . .This publication has 15 references indexed in Scilit:
- AMPICILLIN IN TREATMENT OF: Salmonella typhi CARRIERS AND Brucella melitensis SEPTICÆMIAThe Lancet, 1964
- Treatment of Typhoid Carriers with AmpicillinBMJ, 1964
- AMPICILLIN THERAPY OF SALMONELLA CARRIERSThe American Journal of the Medical Sciences, 1963
- Factors Influencing the Cure of Salmonella CarriersAnnals of Internal Medicine, 1962
- AMPICILLIN A BROAD-SPECTRUM PENICILLINThe Lancet, 1962
- Absorption and Excretion of "Penbritin"BMJ, 1961
- Microbiological Studies on a New Broad-spectrum Penicillin, "Penbritin"BMJ, 1961
- "Penbritin"--A New Broad-spectrum AntibioticBMJ, 1961
- A Broad-spectrum PenicillinBMJ, 1961
- Treatment of the Chronic Alimentary Enteric CarrierBMJ, 1961